SCHEMBL20564627

SCHEMBL20564627

CS(=O)(=O)c1cccc(Nc2ncc3cc(-c4ccccn4)ccc3n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 4/20 0.49
▸ JAK1 P23458 1/20 0.49
▸ TYK2 P29597 1/20 0.49
▸ AURKA O14965 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ MET P08581 1/20 0.49
▸ PDGFRB P09619 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ FLT1 P17948 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ MAPK8 P45983 1/20 0.49
▸ MAPK9 P45984 1/20 0.49
▸ GSK3A P49840 1/20 0.49
▸ GSK3B P49841 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ CDK5 Q00535 1/20 0.49
▸ MST1R Q04912 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20564621 0.84 BRAF (0.53) ACVR1AURKAMAP4K4ABL1LCK
SCHEMBL31006394 0.83 RIPK2 (0.62) ACVR1RIPK2MAP3K5SYKNOD2
SCHEMBL20564698 0.83 RIPK2 (0.62) ACVR1RIPK2MAP3K5SYKNOD2
SCHEMBL20564620 0.82 RIPK2 (0.62) ACVR1AURKAMAP4K4ABL1LCK
SCHEMBL24534195 0.82 RIPK2 (0.60) ACVR1FGFR1CDK9CDK5RIPK2
SCHEMBL20563558 0.80 RIPK2 (0.49) ACVR1JAK1AURKAMAP4K4ABL1
SCHEMBL29498182 0.80 RIPK2 (0.49) ACVR1JAK1AURKAMAP4K4ABL1
SCHEMBL18376613 0.73 JAK2 (0.59) ACVR1AURKAMAP4K4ABL1LCK
SCHEMBL18376612 0.71 RIPK2 (0.61) ACVR1AURKAMAP4K4ABL1LCK
SCHEMBL27113459 0.70 AURKA (0.56) ACVR1AURKAMAP4K4ABL1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2026-05-12 — — US disclosed
US-12516055-B2 Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions TRUSTEES OF TUFTS COLLEGE (US) 2026-01-06 — — US disclosed
EP-4480485-A2 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2024-12-25 — — EP disclosed
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2024-10-03 — — US disclosed
EP-3968991-B1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIV HOUSTON SYSTEM (US) 2024-07-31 — — EP disclosed
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2024-06-18 — — US disclosed
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM 2022-06-23 — — US disclosed
EP-3968991-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2022-03-23 — — EP disclosed
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2022-03-03 — — US disclosed
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2021-11-16 — — US disclosed
WO-2020232190-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM (US) 2020-11-19 — — WO disclosed
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2020-06-04 — — US disclosed
WO-2018213219-A1 PYRIDO[2,3-D]PYRIMIDIN-7ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2018-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 668/4885TYK2 136/4885
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 668/4885TYK2 136/4885
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 671/4885TYK2 141/4885
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 671/4885TYK2 141/4885
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 671/4885TYK2 141/4885
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS RIPK2, RIPK1, RIPK4 ACVR1 7/4885JAK1 1160/4885TYK2 189/4885
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 ACVR1 21/4885JAK1 159/4885TYK2 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback